by admin | Jul 2, 2025 | News & Opinions
By Nick Paul Taylor – Fierce Biotech – The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back into American patients....
by admin | Jul 1, 2025 | News & Opinions
By Alex Philippidis , Fay Lin, PhD and Kevin Davies, PhD – Genetics and Biotechnology News – The reference genome was a “bridge into the future,” but there is still much work that needs significant support. 25 years ago, Francis Collins, MD, PhD, led the...
by admin | Jun 30, 2025 | News & Opinions
By Antonio Pequeño IV – Forbes – Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Key Facts The drug (which has the generic name lenacapavir)...
by admin | Jun 27, 2025 | News & Opinions
By Sant Pau Research Institute – SciTechDaily – A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for future heart disease therapies. An international team of researchers has uncovered...
by admin | Jun 26, 2025 | News & Opinions
By Stanford Report – Stanford researchers have developed a faster, more precise way to model and print vascular systems, solving a critical challenge in fabricating transplantable organs from patients’ own cells. There are more than 100,000 people on organ...
by admin | Jun 25, 2025 | News & Opinions
By Gina Kolata – New York Times – Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes. A single infusion of a stem cell-based treatment may...
